Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirus
肛门微生物群、局部细胞因子和 HIV 在高危人乳头瘤病毒持续存在中的作用
基本信息
- 批准号:10451546
- 负责人:
- 金额:$ 13.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAnaerobic BacteriaAnal canalAnusArchivesBioinformaticsBiometryCell physiologyCervicalCervix UteriCharacteristicsCoitusDataDetectionEnsureEnvironmentEnzymesEpithelialFundingGeneral PopulationGoalsHIVHIV InfectionsHIV SeronegativityHIV SeropositivityHIV riskHIV therapyHPV-High RiskHumanHuman Papilloma Virus VaccineHuman PapillomavirusHuman papilloma virus infectionHuman papillomavirus 16ImmuneImmune ToleranceImmunityImmunologyIncidenceIndividualInfectionInstitutesInterdisciplinary StudyInterventionLeadLearningLesionLogistic RegressionsMalignant NeoplasmsMalignant neoplasm of anusMarylandMediatingMentorsMentorshipModelingMolecular BiologyMucosal ImmunityMucous MembraneNational Cancer InstituteNigeriaParticipantPathway interactionsPatternPopulationPublic HealthRecording of previous eventsResearchResearch PersonnelResearch ProposalsResourcesRiskRoleSamplingScienceSquamous intraepithelial lesionSwabTimeTrainingUgandaUniversitiesUpdateUterine LesionVirusWomanZimbabweanticancer researchantiretroviral therapycancer preventioncancer riskcarcinogenesiscarcinogenicitycohortcommensal bacteriacytokineexperienceindexingmedical schoolsmenmen who have sex with menmicrobialmicrobiomemicrobiome componentsmicrobiotamultidisciplinarypreferencepremalignantpreventprogramsprospectivevaginal microbiomevirology
项目摘要
While uncommon in the general population, there is a marked (60-130 fold) increased risk of
anal cancer in HIV-infected individuals, especially men who have sex with men (MSM). Anal
cancer is caused by high-risk human papillomavirus (HR-HPV) that persists in the anal
epithelium. It is currently not known whether HIV infection alters the anal micro environment,
specifically the microbiota and cytokines, to increase persistence and eventually promote frank
malignancy. The goals of the K07 are to undertake formal training and mentoring in microbiota,
mucosal immunity, and molecular biology of carcinogenesis and to learn how to rigorously
integrate these components analytically to identify cancer prevention markers. Therefore, our
aims are to: 1) characterize the composition of the anal microbiota using hierarchical clustering
and assess cluster membership with a persistently detected HR-HPV a year later for HIV-
negative and HIV-positive men; 2) determine local cytokine profiles from anal swabs and assess
their independent and mediating associations with persistent and non-persistent HR-HPV for
those with and without HIV; and 3) describe the stability of cluster membership over time and
whether that distinguishes persistence among HIV-negative and HIV-positive men. To achieve
these aims, we propose to evaluate prospectively these mucosal interactions using archived
anal swab samples from HIV-infected and HIV-uninfected MSM in an ongoing well
characterized cohort, the TRUST/RV368 study in Nigeria (R01AI20913-01). Dr. Rebecca
Nowak is an exceptional candidate whose research focuses on the mechanisms of HPV
transformation during HIV infection. Much of her research has originated in Uganda, Zimbabwe,
and Nigeria which has resulted in her focus on global cancer research, one of the priorities for
the National Cancer Institute. Dr. Nowak has strong institutional support from the Institute of
Human Virology at the University of Maryland School of Medicine. She will have guaranteed
protected research time and access to a wealth of resources that will ensure a successful
transition to an independently funded investigator. Her robust training plan includes: 1) high
quality mentorship from her primary mentor, Dr. Kevin Cullen, as well as co-mentors in the field
of microbiome (Dr. Jacque Ravel), biostatistics (Dr. Soren Bentzen), mucosal immunology (Dr.
Raina Fichorova); 2) coursework in fundamental immunology with a focus on the mucosa; 3)
training in bioinformatics; and 4) experience in multidisciplinary team science. With the training
and experience, Dr. Nowak will be prepared to seek R01 funding to establish a multidisciplinary
research program in carcinogenic viruses during HIV infection.
虽然在一般人群中不常见,但患此病的风险显着增加(60-130 倍)
HIV 感染者,尤其是男男性行为者 (MSM) 的肛门癌。肛门
癌症是由持续存在于肛门中的高危人乳头瘤病毒 (HR-HPV) 引起的
上皮。目前尚不清楚 HIV 感染是否会改变肛门微环境,
特别是微生物群和细胞因子,以增加持久性并最终促进坦率
恶性肿瘤。 K07 的目标是进行微生物群方面的正式培训和指导,
粘膜免疫和致癌的分子生物学,并学习如何严格
通过分析整合这些成分来识别癌症预防标志物。因此,我们的
目标是:1)使用层次聚类来表征肛门微生物群的组成
一年后,通过持续检测到的 HR-HPV 来评估集群成员资格,以检测 HIV-
阴性和艾滋病毒阳性男性; 2) 从肛门拭子中确定局部细胞因子谱并评估
它们与持续性和非持续性 HR-HPV 的独立和中介关联
感染和未感染艾滋病毒的人; 3) 描述集群成员资格随时间的稳定性
这是否能区分艾滋病毒阴性和艾滋病毒阳性男性的持久性。达到
这些目标,我们建议使用存档的内容前瞻性地评估这些粘膜相互作用
来自正在进行的井中感染 HIV 和未感染 HIV 的 MSM 的肛门拭子样本
特征队列,尼日利亚的 TRUST/RV368 研究 (R01AI20913-01)。丽贝卡博士
Nowak 是一位杰出的候选人,他的研究重点是 HPV 的机制
HIV感染期间的转化。她的大部分研究起源于乌干达、津巴布韦、
和尼日利亚,这使她专注于全球癌症研究,这是该中心的优先事项之一
美国国家癌症研究所。 Nowak 博士得到了研究所的强有力的机构支持
马里兰大学医学院人类病毒学。她一定会保证
受保护的研究时间和丰富的资源,这将确保成功
过渡为独立资助的研究者。她稳健的培训计划包括:1)高
她的主要导师 Kevin Cullen 博士以及该领域的共同导师提供优质指导
微生物组学(Jacque Ravel 博士)、生物统计学(Soren Bentzen 博士)、粘膜免疫学(Dr. Soren Bentzen)
雷娜·费霍洛娃); 2)基础免疫学课程,重点是粘膜; 3)
生物信息学培训; 4)多学科团队科学的经验。随着训练
和经验,Nowak 博士将准备寻求 R01 资金来建立多学科
HIV感染期间致癌病毒的研究计划。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies.
根据人类免疫缺陷病毒状态、性别和男性性行为,16 164 名个体肛门人乳头瘤病毒感染的发病率和清除率:34 项纵向研究的国际汇总分析。
- DOI:
- 发表时间:2023-02-08
- 期刊:
- 影响因子:0
- 作者:Wei, Feixue;Goodman, Marc T;Xia, Ningshao;Zhang, Jun;Giuliano, Anna R;D'Souza, Gypsyamber;Hessol, Nancy A;Schim van der Loeff, Maarten F;Dai, Jianghong;Neukam, Karin;de Pokomandy, Alexandra;Poynten, I Mary;Geskus, Ronald B;Burgos, Joaquin;Et
- 通讯作者:Et
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rebecca G. Nowak其他文献
Rebecca G. Nowak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rebecca G. Nowak', 18)}}的其他基金
Evaluating immunity to oral human papillomavirus to understand the lower oropharyngeal cancer risk among MSM
评估对口腔人乳头瘤病毒的免疫力,以了解 MSM 中口咽癌的风险较低
- 批准号:
10401518 - 财政年份:2021
- 资助金额:
$ 13.54万 - 项目类别:
Evaluating immunity to oral human papillomavirus to understand the lower oropharyngeal cancer risk among MSM
评估对口腔人乳头瘤病毒的免疫力,以了解 MSM 中口咽癌的风险较低
- 批准号:
10491845 - 财政年份:2021
- 资助金额:
$ 13.54万 - 项目类别:
Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirus
肛门微生物群、局部细胞因子和 HIV 在高危人乳头瘤病毒持续存在中的作用
- 批准号:
9979821 - 财政年份:2018
- 资助金额:
$ 13.54万 - 项目类别:
Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirus
肛门微生物群、局部细胞因子和 HIV 在高危人乳头瘤病毒持续存在中的作用
- 批准号:
10217043 - 财政年份:2018
- 资助金额:
$ 13.54万 - 项目类别:
相似国自然基金
厌氧菌藻生物膜降解噻唑化合物的氢营养代谢机理研究
- 批准号:52300043
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道厌氧菌产新颖鞘磺脂及其免疫调节活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微氧环境下兼性厌氧菌和产甲烷菌降解长链脂肪酸的协同机制
- 批准号:52170037
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
兼性厌氧菌JPG1在不同氧条件下对铜胁迫的抗性机制与调控
- 批准号:52070037
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
肠道厌氧菌S.Moorei通过抑制AGK调节浸润性CD8+T细胞糖酵解增强直肠癌的辐射抵抗及机制
- 批准号:82073329
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Hypoxia-activated probiotic agents for breast cancer
用于乳腺癌的缺氧激活益生菌制剂
- 批准号:
10660233 - 财政年份:2023
- 资助金额:
$ 13.54万 - 项目类别:
The role of the gut microbiome in ICB-induced anti-tumor response and toxicity
肠道微生物组在 ICB 诱导的抗肿瘤反应和毒性中的作用
- 批准号:
10606715 - 财政年份:2023
- 资助金额:
$ 13.54万 - 项目类别:
Investigating the Function of Fimbriae-forming Lipoprotein in Porphyromonas gingivalis
牙龈卟啉单胞菌菌毛形成脂蛋白的功能研究
- 批准号:
10749647 - 财政年份:2023
- 资助金额:
$ 13.54万 - 项目类别:
Project 1: Mucosal toxin subunit immunization as a strategy for C. difficile vaccine development
项目 1:粘膜毒素亚基免疫作为艰难梭菌疫苗开发的策略
- 批准号:
10625692 - 财政年份:2023
- 资助金额:
$ 13.54万 - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10716654 - 财政年份:2023
- 资助金额:
$ 13.54万 - 项目类别: